Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-10-04
1991-06-11
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514526, 530350, 530839, 530848, 530854, A61K 3702
Patent
active
050232380
ABSTRACT:
A composition comprising nerve growth factor and 2-amino-1,1,3-tricyano-1-propene useful for the induction, stimulation, and maintenance of nerve growth, and methods of potentiating choline O-acetyltransferase and tyrosine hydroxylase by 2-amino-1,1,3-tricyano-1-propene are disclosed.
REFERENCES:
patent: 2719861 (1955-10-01), Carboni
patent: 3311539 (1967-03-01), Eberts
patent: 4287184 (1981-09-01), Young
DaVanzo et al., Archive Int'l. Pharmacodyn, vol. 31, pp. 299-308 (1963).
Varon et al., Biochemistry, vol. 6, No. 7, pp. 2202-2209 (1967).
Houlihan et al., Experimental Neurology, vol. 10, No. 2, pp. 183-189 (1964).
Green et al., Ann. Rev. Neurosci. 1980, pp. 353-403.
J. W. Paul and J. P. DaVanzo, Society for Neuroscience Abstracts, vol. 15, Part 1, 1989, p. 868.
Theo Hagg, et al., Brain Research, 505 (1989) 29-38.
F. Hefti, The Journal of Neuroscience, Aug. 1986, 6(8):2155-2162.
B. J. Gudzinowicz, et al., Drug Dynamics for Analytical, Clinical, and Biological Chemists, 1984, pp. 9 and 10.
B. K. Schrier, et al., The Pharmacologist, 30, 128.10 (1988), received Sept. 27, 1988.
J. P. DaVanzo, et al., The Pharmacologist, 30, 128.2 (1988), received Sept. 27, 1988.
J. W. Paul and J. P. DaVanzo, The Pharmacologist, 30, 59.9 (1988) received Sept. 27, 1988.
B. A. Yankner and E. M. Shooter, Ann. Rev. Biochem., 51, 845-868 (1982).
F. Hefti and W. J. Weiner, Annals of Neurology, 20, 275 (1986).
K. L. Davis and R. C. Mohs, The New England Journal of Medicine, 315, 1286 (1986).
S. H. Appel, Annals of Neurology, 10, 499 (1981).
B. K. Schrier and L. Shuster, J. Neurochemistry, 14, 977 (1967).
T. Nagatsu, et al., Analyt. Biochem., 9, 122 (1964).
J. P. DaVanzo, et al., Archive Int. Pharmacodyn., 41, 299 (1963).
H. Gnahn, et al., Developmental Brain Research, 9 45, (1983).
S. Halegous and J. Patrick, Cell, 22, 571 (1980).
DaVanzo John P.
Paul, Jr. Joseph W.
Daus Donald G.
Hoechst-Roussel Pharmaceuticals Inc.
Wittekind Raymond R.
LandOfFree
Nerve growth induction, stimulation and maintenance and enzyme p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nerve growth induction, stimulation and maintenance and enzyme p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nerve growth induction, stimulation and maintenance and enzyme p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-782646